Commentary
Archer’s Chief Technology Officer, Simon Ruffell, spoke with ausbiz about the latest developments and milestones of its 12CQ quantum project, how its Biochip uses graphene to test for diseases such as chronic kidney disease in the home, and its quantum-based TMR Sensors.
Watch the interview here:
Newsletter
Commentary
Designed by Aaron Knight.
